|Author(s)/Faculty: Martha Gulati, MD, MS, FACC, FAHA, FASPC; Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC; Alison L. Bailey, MD, FASPC, FACC; Pam R. Taub, MD, FACC, FASPC|
Cardiovascular disease (CVD) is the leading cause of death globally, and women are disproportionately affected, showing higher morbidity and mortality rates than men. This trend has continued, despite recent advances in awareness campaigns, gender-based guidelines, as well as effective available therapies. In the United States, heart disease accounts for approximately 1 out of every 5 female deaths, with almost 300,000 deaths in women each year. In addition to traditional cardiovascular (CV) risk factors, women often carry several nontraditional risk factors, many of which are related to pregnancy, hormonal influences, or comorbid disorders. Furthermore, women are less likely to receive guideline-recommended diagnostic testing and therapies.
The faculty for this CME activity will address CVD risk factors, tools, and guidelines to screen females for CV risk. They also will examine recent advances in lifestyle modifications, primary and secondary prevention, and considerations for women with type 2 diabetes to improve health outcomes and reduce CVD mortality.